西亚试剂：Reprogramming of T Cells from Human Peripheral Blood

发布时间：2025-09-04

Reprogramming of T Cells from Human Peripheral Blood
Yuin-Han Loh1, 2, Odelya Hartung1, 2, Hu Li3, 4, Chunguang Guo5, 6, 7, Julie M. Sahalie1, 2, Philip D. Manos1, 2, Achia Urbach1, 2, Garrett C. Heffner1, 2, Marica Grskovic8, Francois Vigneault7, M. William Lensch1, 2, 5, In-Hyun Park1, 2, Suneet Agarwal1, 2, George M. Church7, James J. Collins3, 4, 5, Stefan Irion8, , and George Q. Daley1, 2, 5, 9, 10

Stem Cell Transplantation Program, Division of Pediatric Hematology Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
2 Harvard Stem Cell Institute, Cambridge, MA 02138, USA
3 Department of Biomedical Engineering and Center for BioDynamics, Boston University, Boston, MA 02215, USA
4 Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
5 Howard Hughes Medical Institute, Boston, MA 02115, USA
6 Immune Diseases Institute, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA
7 Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
8 iPierian, Inc. South San Francisco, CA 94080, USA
9 Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA
10 Manton Center for Orphan Disease Research, Boston, MA 02115, USA

Human induced pluripotent stem cells (iPSCs) derived from somatic cells of patients hold great promise for modeling human diseases. Dermal fibroblasts are frequently used for reprogramming, but require an invasive skin biopsy and a prolonged period of expansion in cell culture prior to use. Here, we report the derivation of iPSCs from multiple human blood sources including peripheral blood mononuclear cells (PBMCs) harvested by routine venipuncture. Peripheral blood-derived human iPSC lines are comparable to human embryonic stem cells (ESCs) with respect to morphology, expression of surface antigens, activation of endogenous pluripotency genes, DNA methylation, and differentiation potential. Analysis of immunoglobulin and T cell receptor gene rearrangement revealed that some of the PBMC iPSCs were derived from T cells, documenting derivation of iPSCs from terminally differentiated cell types. Importantly, peripheral blood cells can be isolated with minimal risk to the donor and can be obtained in sufficient numbers to enable reprogramming without the need for prolonged expansion in culture. Reprogramming from blood cells thus represents a fast, safe, and efficient way of generating patient-specific iPSCs.

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供此产品的详细信息如密度,含量,分子式,分子量等均可在西亚官网查询
相关产品如汞乙酸汞氯化汞氧化汞碘化汞硫酸汞硝酸汞溴化汞硝酸亚汞氯化亚汞乙酸苯汞碘化汞钾硫氰酸汞氯化氨基汞三氯生三氯氧磷三氯乙烯水合氯醛三氯化磷三氯化钌三氯化钛三氯化铱三氯化铑三氯硫磷三氯乙烷三氯甲烷三氯卡班TCC 1,3,5-三氯苯 1,2,4-三氯苯 1,2,3-三氯苯无水氯化铝三氯乙酸酐三氯乙酸钠碘甲烷二碘甲烷三碘甲烷三氟碘甲烷硫酸二甲酯氯磺酸苯硫酚苯硫酚钠 3-氨基苯硫酚 2,6-二氯苯硫酚 2,4-二氯苯硫酚 2,5-二氯苯硫酚 2-甲氧基苯硫酚 2-氯乙醇等均有销售.欢迎订购

上一篇：西亚试剂：14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to met
下一篇：西亚试剂：Matrix-Embedded Osteocytes Regulate Mobilization of Hematop